Actively Recruiting
Evaluating How the Urine Test Cxbladder Triage Plus Influences Cystoscopy Decisions in Adults with Microscopic Blood in Urine
Led by Pacific Edge Limited · Updated on 2026-07-02
1000
Participants Needed
20
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating adult patients who consult a urologist due to microscopic blood in their urine, a condition known as microhematuria. This blood is only visible under a microscope and can be caused by several factors, including bladder cancer. Although bladder cancer is a major concern, it is found in only a small number of these patients. The study aims to assess how the use of the urine test Cxbladder Triage Plus influences the number of cystoscopies performed in these patients. Participants provide a urine sample for the Cxbladder Triage Plus test, which analyzes RNA and DNA biomarkers to estimate the likelihood of urothelial carcinoma, the most common type of bladder cancer. Participants are randomly assigned to one of two groups in the test group, the urologist receives the test result and discusses it with the patient to decide together whether to proceed with cystoscopy in the control group, neither the urologist nor the patient receives the test result, and decisions follow standard care. If the urologist chooses not to follow the test recommendation, they complete a brief survey explaining their decision. Data on procedures and diagnoses are collected for up to about 9 months. During the study, participants follow the chosen diagnostic pathway with monitoring of procedures performed and diagnoses made. The main outcome is the rate of cystoscopies performed within 3 months of the decision. Additional measures include detection of urothelial carcinoma, performance of the Cxbladder test, persistence of hematuria, imaging rates, and missed cancers. The study will compare these outcomes between the groups to understand the tests impact on diagnostic decisions and patient management.
CONDITIONS
Brief Title
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Research Team
D
Donna Smith
T
Tony Lough, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here